中國節能海東青(02228.HK):已刊發綜合年度財務業績 繼續停牌
格隆匯4月29日丨中國節能海東青(02228.HK)發佈公告,2019年11月26日,公司向聯交所提交已更新的新上市申請。公司已取得監管機構就有關新上市申請的通函提出的進一步意見,而公司正連同所有相關專業各方就有關意見作出迴應。通函將於公司就新上市申請取得上市委員會及證券及期貨事務監察委員會原則上批准後,於實際可行情況下儘快寄發予股東。
此外,公司已於2020年3月30日刊發集團截至2019年12月31日止年度的綜合年度財務業績。公司股份將繼續暫停買賣直至另行通知以及完全達成復牌條件及聯交所可能施加的有關其他進一步條件為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.